Cellularity as a predictive tool for mesenchymal stem cell concentration in bone marrow concentrates: Implications for regenerative medicine
2024

Cellularity as a Predictive Tool for Stem Cell Concentration in Bone Marrow

Sample size: 41 publication Evidence: moderate

Author Information

Author(s): Klaus Werner Labarre, Peter Ansgar Grathwol, Gerald Zimmermann

Primary Institution: Department of Trauma Surgery, Theresienkrankenhaus, Mannheim, Germany

Hypothesis

Can the total cell count in bone marrow concentrates serve as a reliable indicator of mesenchymal stem cell numbers?

Conclusion

Total cell counts can be used to estimate mesenchymal stem cell concentrations in bone marrow concentrates, but cellularity does not indicate a higher MSC content.

Supporting Evidence

  • The mean percentage of CD271+ CD45− cells was 0.03%.
  • Cellularity varied significantly among samples, with a mean of 6 million cells/ml.
  • A strong correlation was observed between BMC cellularity and MSC concentration.

Takeaway

This study found that counting the total number of cells in bone marrow can help estimate how many stem cells are present, but just having a lot of cells doesn't mean there are more stem cells.

Methodology

Bone marrow aspirates were collected from patients and processed using density gradient centrifugation and flow cytometry to analyze cell subsets.

Potential Biases

Potential bias in sample collection and processing methods affecting cell counts.

Limitations

High variability in cellularity and MSC percentages among samples; limited data on the composition and quality of BMCs.

Participant Demographics

Patients undergoing knee or hip arthroplasty, with no significant differences in demographics across collection sites.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.bonr.2024.101820

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication